Insider Selling: Cerebras Systems (NASDAQ:CBRS) Director Sells $10,909,000.00 in Stock

Cerebras Systems Inc. (NASDAQ:CBRS) Director Steven Vassallo sold 50,000 shares of the company’s stock in a transaction on Friday, August 14th. The shares were sold at an average price of $218.18, for a total value of $10,909,000.00. Following the completion of the transaction, the director directly owned 49,599 shares in the company, valued at approximately $10,821,509.82. This represents a 50.20% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Cerebras Systems Trading Down 2.7%

CBRS stock opened at $209.85 on Friday. Cerebras Systems Inc. has a fifty-two week low of $160.81 and a fifty-two week high of $386.34. The stock’s fifty day moving average price is $208.60.

Cerebras Systems (NASDAQ:CBRS) last announced its earnings results on Wednesday, August 12th. The company reported ($2.98) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.21) by ($2.77). The firm had revenue of $209.87 million for the quarter. Cerebras Systems’s quarterly revenue was up 74.3% compared to the same quarter last year. As a group, equities analysts expect that Cerebras Systems Inc. will post -0.52 EPS for the current fiscal year.

Institutional Investors Weigh In On Cerebras Systems

A number of large investors have recently bought and sold shares of CBRS. Bank of New York Mellon Corp acquired a new position in shares of Cerebras Systems in the 2nd quarter valued at approximately $6,118,000. Tiger Pacific Capital LP acquired a new stake in shares of Cerebras Systems during the 2nd quarter worth approximately $221,000. Ratan Capital Management LP acquired a new stake in shares of Cerebras Systems during the 2nd quarter worth approximately $4,641,000. Wellington Management Group LLP bought a new position in Cerebras Systems in the second quarter valued at approximately $194,853,000. Finally, Montanova Capital LLC bought a new position in Cerebras Systems in the second quarter valued at approximately $37,990,000.

Analyst Ratings Changes

CBRS has been the topic of several recent research reports. Mizuho lowered their target price on shares of Cerebras Systems from $310.00 to $300.00 and set an “outperform” rating on the stock in a report on Thursday, August 13th. Craig Hallum initiated coverage on Cerebras Systems in a research note on Monday, June 8th. They issued a “buy” rating and a $325.00 price target for the company. UBS Group increased their price target on Cerebras Systems from $320.00 to $330.00 and gave the stock a “buy” rating in a research report on Thursday, August 13th. Wall Street Zen upgraded Cerebras Systems from a “sell” rating to a “hold” rating in a research note on Saturday, August 15th. Finally, TD Cowen initiated coverage on Cerebras Systems in a report on Monday, June 8th. They issued a “buy” rating and a $275.00 price objective for the company. One investment analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Cerebras Systems has a consensus rating of “Moderate Buy” and a consensus price target of $299.90.

Cerebras Systems News Roundup

Here are the key news stories impacting Cerebras Systems this week:

• Positive Sentiment: Cerebras and Callosum announced a partnership to deliver ultra-low-latency, heterogeneous AI inference for agentic applications. The agreement strengthens Cerebras’ position in real-time AI workloads and could expand its commercial reach if customers adopt the combined offering. Cerebras and Callosum partnership
• Positive Sentiment: The company’s CS-4 rack-scale accelerator is being promoted as up to 30 times faster than GPU-based solutions for certain inference workloads. The launch supports Cerebras’ strategy of competing with Nvidia in fast, real-time AI processing. Cerebras CS-4 announcement
• Positive Sentiment: Rosenblatt Securities and Needham reaffirmed “buy” ratings with $300 price targets. Unusually heavy call-option activity and reports of manufacturing expansion, a large backlog, and potential growth in AI inference are also supporting bullish interest.
• Neutral Sentiment: The CS-4 speed advantage is primarily a company claim and must be validated through independent benchmarks, customer deployments, and sustained sales. The technology announcement may therefore boost sentiment before materially affecting financial results.
• Negative Sentiment: CEO Andrew Feldman sold 26,644 shares worth approximately $5.9 million to cover tax withholding tied to vested equity awards. Although the stated reason reduces its significance, the sale cut his ownership by 28.5%. Cerebras CEO insider sale
• Negative Sentiment: Director Eric Vishria sold about $15.7 million of stock, while director Steven Vassallo sold approximately $10.9 million. The transactions, even where conducted under trading plans, may reinforce profit-taking concerns.
• Negative Sentiment: Cerebras recently reported a $2.98-per-share loss versus the expected $0.21 loss, despite 74.3% year-over-year revenue growth to $209.9 million. The sharp earnings miss keeps profitability and valuation as important risks for CBRS.

About Cerebras Systems

Cerebras Systems is a technology company focused on building artificial intelligence infrastructure, including hardware and software designed to accelerate deep learning and large-scale AI workloads. The company is best known for its wafer-scale processor architecture, which is intended to provide high-performance compute for training and inference applications.

In addition to its AI chips, Cerebras offers systems and related software tools that support researchers and enterprises working with machine learning models.